Webinar: Identification of Antibodies against Challenging Targets using High Throughput, Multiplexed Approaches
Antibody-based therapeutics are unique in that they are specific in terms of binding to their target antigen. Evaluation of cross-species and/or epitope reactivity of antibodies during the screening phase is of high importance.
This webinar overviews:
- The evaluation of cross species reactivity of antibodies in the primary screening phase using the Intellicyt platform
- Applications of the Intellicyt platform in different phases of the drug discovery process
Complete the form below to watch this webinar.